Literature DB >> 6160221

The discrimination between different blood-CSF barrier dysfunctions and inflammatory reactions of the CNS by a recent evaluation graph for the protein profile of cerebrospinal fluid.

H Reiber.   

Abstract

A graph for the evaluation of the CSF-protein profile is presented as a basic program for the clinical-neurochemical laboratory. The graph has the following advantages: Simultaneous information on the functional state of the blood-CSF barrier and the inflammatory response of the CNS; maximal sensitivity for the determination of a pathological local IgG production in CNS--with the possibility of calculating the IgG fraction in CSF originating from the CNS; minimal number of protein assays necessary (albumin and IgG in serum and CSF); suitable for the demonstration of the course of the disease in a single patient as well as for demonstration of a group of cases for statistical purposes. Complementary chemical investigations and the correspondence with the clinical diagnosis are discussed for a number of typical cases. Two different types of blood-CSF barrier dysfunctions are discriminated by a proportional and a dis-proportionate increase of the CSF/serum protein concentration gradients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6160221     DOI: 10.1007/BF00313347

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  Protein size and cerebrospinal fluid composition.

Authors:  K Felgenhauer
Journal:  Klin Wochenschr       Date:  1974-12-15

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  Serum-CSF protein gradients, the blood-GSF barrier and the local immune response.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1978-05-18       Impact factor: 4.849

4.  [Relationship between immunoglobulin levels in cerebrospinal fluid and serum].

Authors:  B Weisner; W Bernhardt
Journal:  Fortschr Med       Date:  1978-10-05

5.  Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation.

Authors:  K Ganrot; C B Laurell
Journal:  Clin Chem       Date:  1974-05       Impact factor: 8.327

6.  [A rapid and simple nephelometric assay for total protein in cerebrospinal fluid (author's transl)].

Authors:  H Reiber
Journal:  J Clin Chem Clin Biochem       Date:  1980-02

7.  Discrimination of elevated immunoglobulin concentrations in CSF due to inflammatory reaction of the central nervous system and blood-brain-barrier dysfunction.

Authors:  K Eickhoff; R Heipertz
Journal:  Acta Neurol Scand       Date:  1977-12       Impact factor: 3.209

8.  Myelin basic protein in cerebrospinal fluid from children.

Authors:  A Kohlschütter
Journal:  Eur J Pediatr       Date:  1978-03-13       Impact factor: 3.183

9.  [Diagnostic significance of lactate concentration in CSF in patients with meningitis (author's transl)].

Authors:  T O Kleine; K Baerlocher; V Niederer; H Keller; F Reutter; W Tritschler; W Bablok
Journal:  Dtsch Med Wochenschr       Date:  1979-04-13       Impact factor: 0.628

10.  [Calculation of the IgG fraction of cerebrospinal fluid locally synthesized in the central nervous system (author's transl)].

Authors:  H Reiber
Journal:  J Clin Chem Clin Biochem       Date:  1979-09
View more
  35 in total

1.  Critical evaluation of the biological role of IgM in cerebrospinal fluid in inflammatory and other diseases of the nervous system.

Authors:  J Svatonová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

2.  Immunological differentiation between neuroborreliosis and multiple sclerosis.

Authors:  J Heller; G Holzer; K Schimrigk
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

3.  Borrelia burgdorferi myelitis presenting as a partial stiff man syndrome.

Authors:  R Martin; H M Meinck; W Schulte-Mattler; K Ricker; H G Mertens
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

4.  Late onset globoid leukodystrophy: unusual clinical and CSF findings.

Authors:  S Rolando; M Cremonte; A Leonardi
Journal:  Ital J Neurol Sci       Date:  1990-02

5.  The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.

Authors:  K J Lamers; B M Uitdehaag; O R Hommes; W Doesburg; R A Wevers; W J von Geel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-10       Impact factor: 10.154

6.  Intrathecal production of HIV antibodies in suspected AIDS encephalopathy.

Authors:  R Biniek; M Bartholome; M Schulz; H J Lehmann; H Gesemann; N Scheiermann; N H Brockmeyer; M Derks; K Balzer
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

7.  Study of the cerebrospinal fluid penetrability of ofloxacin.

Authors:  G Stübner; W Weinrich; U Brands
Journal:  Infection       Date:  1986       Impact factor: 3.553

8.  Intrathecal synthesis of virus-specific oligoclonal antibodies in patients with enterovirus infection of the central nervous system.

Authors:  R Kaiser; R Dörries; R Martin; U Fuhrmeister; K F Leonhardt; V ter Meulen
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

9.  Cerebrospinal fluid immunoglobulins and virus-specific antibodies in disorders affecting the facial nerve.

Authors:  T Weber; S Jürgens; W Lüer
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

10.  [Characteristic cerebrospinal fluid findings and clinical aspects of lymphocytic meningoradiculitis].

Authors:  C R Hornig; O Busse; W Dorndorf
Journal:  Klin Wochenschr       Date:  1984-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.